20 results on '"Luchenko, Victoria"'
Search Results
2. Data from Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers
3. Supplementary Figure 1 from Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers
4. MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor
5. Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin
6. Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma
7. Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras
8. Abstract 5536: Short-term romidepsin treatment combined with MAPK pathway inhibition results in decreased mitochondrial hexokinase 2, increased mitochondrial Bim and apoptosis in BRAF mutant cancers
9. Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers
10. Abstract 3399: Resistance to the histone deacetylase inhibitor romidepsin is associated with degradation of Bim following MAPK pathway activation.
11. Abstract B9: Activated MAPK Pathway Mediates Resistance to Romidepsin via Bim Degradation in Romidepsin-Selected HuT 78 Cells
12. Abstract 4708: Short-term romidepsin treatment combined with mitogen-activated protein kinase and phosphatidylinositol 3-kinase inhibition causes increased Bim expression and cell death in KRAS mutant cell lines
13. Abstract 4709: Combined mitogen-activated protein kinase pathway inhibition with short-term romidepsin treatment induces proapoptotic Bim and cell death in BRAF mutant cancers
14. A Pharmacodynamic Study of the P-glycoprotein Antagonist CBT-1® in Combination With Paclitaxel in Solid Tumors
15. Histone Deacetylase Inhibitors: Emerging Mechanisms of Resistance
16. Schedule-dependent synergy of histone deacetylase inhibitors with DNA damaging agents in small cell lung cancer
17. Heat shock enhances CMV-IE promoter-driven metabotropic glutamate receptor expression and toxicity in transfected cells
18. Abstract 2620: Identification of cell context specific and pleiotropic effects of the histone deacetylase inhibitors romidepsin (depsipeptide) and vorinostat (SAHA)
19. Abstract 5372: Mechanisms of synergy of histone deacetylase inhibitors, belinostat and depsipeptide, with DNA damaging agents, etoposide and cisplatin in small cell lung cancer cell lines
20. Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation – Possible role as a dependence receptor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.